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Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27
transgenic rats with chronic colitis are mediated by both major
histocompatibility class II and HLA-B27 molecules
Introduction
Ulcerative colitis and Crohn’s disease are two chronic dis-
eases characterized by relapsing inflammation of the distal
intestinal tract. Their aetiologies remain unclear but an
unrestrained cell-mediated immune response to non-
pathogenic commensal luminal bacteria in a genetically
susceptible host has been proposed.1 Substantial data
from clinical observations and animal experiments impli-
cate activated CD4+ T lymphocytes, which accumulate in
inflamed tissues.1,2 Evidence incriminates a polarized T
helper 1 immune response with exaggerated interferon
(IFN)-c, interleukin-12 (IL-12), and tumour necrosis fac-
tor (TNF) production. In several murine models, intesti-
nal inflammation can be prevented by neutralization of
endogenous IL-123,4 and IFN-c5 and dramatically reduced
by administration of anti-TNF antibody.5,6 Likewise, anti-
TNF and anti-IL-12 antibodies induce rapid clinical
responses in Crohn’s disease patients.7,8
Transgenic (TG) rats expressing the human major
histocompatibility complex (MHC) class I gene, HLA-B27
and its associated light chain, human b2-microglobulin
spontaneously develop a progressive, multisystemic dis-
ease including gastritis, colitis, and arthritis when main-
tained in specific pathogen-free (SPF) conditions.9 The
essential role of T cells in disease pathogenesis has been
demonstrated in cell transfer experiments using athymic
HLA-B27 TG nude rats which, unlike euthymic TG rats,
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Summary
Rats transgenic (TG) for the human major histocompatibility complex
(MHC) class I HLA-B27 and b2-microglobulin genes develop chronic coli-
tis under specific pathogen-free (SPF) but not sterile (germ-free, GF) con-
ditions. We investigated the role of antigen-presenting molecules involved
in generating immune responses by CD4+ mesenteric lymph node (MLN)
cells from colitic HLA-B27 TG rats to commensal enteric micro-organ-
isms. All TG MLN cells expressed HLA-B27. A higher level of MHC class
II was expressed on cells from TG rats, both SPF and GF, compared to
non-TG littermates. In contrast, rat MHC class I expression was lower on
TG than non-TG cells. Both TG and non-TG antigen presenting cells (APC)
pulsed with caecal bacterial antigens induced a marked interferon-c
(IFN-c) response in TG CD4+ T lymphocytes but failed to stimulate
non-TG cells. Blocking MHC class II on both TG and non-TG APC
dramatically inhibited their ability to induce TG CD4+ T cells to pro-
duce IFN-c. Blocking HLA-B27 on TG APC similarly inhibited IFN-c
responses. When the antibodies against MHC class II and HLA-B27 were
combined, no APC-dependent IFN-c response was detected. These
data implicate both native rat MHC class II and TG HLA-B27 in CD4+
MLN T-cell IFN-c responses to commensal enteric microflora in this
colitis model.
Keywords: CD4+ T-cell responses; HLA-B27; MHC class II; enteric bacter-
ial antigens; transgenic rats
Abbreviations: APC, antigen-presenting cells; ELISA, enzyme-linked immunosorbent assay; GF, germ-free; IFN, interferon;
IL, interleukin; KLH, keyhole limpet haemocyanin; MFI, mean fluorescence intensity; MHC, major histocompatibility complex;
MLN, mesenteric lymph node; PIRs, paired immunoglobulin-like receptors; SPF, specific pathogen free; TCR, T-cell receptor;
TG, transgenic; TNF, tumour necrosis factor; UPR, unfolded protein response.
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fail to develop intestinal inflammation unless they are
reconstituted with T cells.10
Antigen-presenting cells (APC) are critical for induc-
tion of inflammatory disease. Inflammation can be trans-
ferred by engraftment of bone marrow from HLA-B27
TG nu/nu donors into non-TG recipients.10,11 Another
study12 showed that freshly isolated colonic lamina pro-
pria dendritic cells from CD4+ T-cell reconstituted immuno-
deficient mice with severe colitis but not from healthy,
syngeneic controls could induce a high IFN-c response in
CD4+ cells. It is likely therefore, that chronic intestinal
inflammation is triggered by APC interacting with T cells.
Mucosal microflora are also crucial to the initiation
and perpetuation of spontaneous colitis in animal mod-
els.1,2 Genetically susceptible rodents raised in germ-free
(GF) conditions do not develop colitis13–16 or have mark-
edly attenuated experimental intestinal inflammation.17 In
contrast, colonization of these susceptible GF animals
with commensal SPF bacteria rapidly induces gut inflam-
mation. Moreover, broad-spectrum antibiotics can pre-
vent as well as reverse experimental colitis.18–21
Although these observations suggest that a genetic pre-
disposition, commensal intestinal micro-organisms, acti-
vated APC and CD4+ T lymphocytes are key factors for
the development of colitis, neither the triggering antigens
nor the mechanisms by which bacterial products activate
immune cells have been identified. The aim of the present
study therefore was to evaluate activation of HLA-B27 TG
CD4+ T cells by physiologically relevant components of
intestinal micro-organisms. Our results show that IFN-c
is induced during in vitro coculture of caecal bacterial
lysate-pulsed APC with CD4+ T cells from HLA-B27 TG
rats with colitis. CD4+ cells from non-TG littermates do
not produce IFN-c in parallel cocultures. Moreover, we
demonstrate a role for both HLA-B27 and endogenous




HLA-B27 TG rats of the high transgene copy number line
designated 33-3 and non-TG littermates on an inbred
F344 background, originally obtained from Dr Joel D.
Taurog (South-western Medical School, Dallas, TX), were
maintained in a SPF environment at the University of
North Carolina at Chapel Hill or under GF conditions in
the Gnotobiotic Animal Core of the Center for Gastro-
intestinal Biology and Disease at the College of Veterinary
Medicine, North Carolina State University. Offspring were
genotyped for the HLA-B27 transgene by polymerase
chain reaction analysis of DNA from tail clippings; the
presence of HLA-B27 on TG MLN cells was further con-
firmed by flow cytometry.
Rats of both sexes, 4–6 months old, when the SPF TG
rats uniformly developed clinically evident colitis, were
used throughout the studies. The investigation was
approved by the Institutional Animal Care and Use
Committees of the University of North Carolina at
Chapel Hill, and North Carolina State University.
Preparation of caecal bacterial lysate
Caecal bacterial lysate was prepared according to the
method described by Cong et al.22 Briefly, caecal contents
from three to four SPF non-TG rats were vortexed, trea-
ted with 20 lg/ml DNA-ase and 37 mg/ml MgCl2, and
disrupted using 01 mm glass beads in a mini-bead
beater for 3 min (Biospec Products, Bartlesville, OK). The
supernatant was collected after centrifugation and filter-
sterilized through a 045 lm filter. The protein concentra-
tion was determined using a standard assay (Biorad
Laboratories, Hercules, CA).
Preparation of single-cell suspensions and enriched
lymphoid cell subpopulations
MLNs were collected from HLA-B27 TG and non-TG
rats, and single cell suspensions were prepared by gentle
mechanical teasing. Cell were washed, counted and resus-
pended in RPMI for fractionation or flow cytometry.
APC preparation
APC were prepared from MLNs by rabbit comple-
ment-mediated lysis of T cells bound by IgM anti-rat
CD3 monoclonal antibody (Clone 1F4, PharMingen, San
Diego, CA). The resulting population from non-TG rats
contained over 96% surface immunoglobulin-expressing
cells, a characteristic of B cells, and less than 4% CD4+ or
CD8+ cells. In the case of TG rats, more than 92% of the
remaining cells expressed surface immunoglobulin and
less than 7–8% positive for CD4 or CD8.
CD4+ T lymphocyte purification
CD4+ T cells were enriched from MLN cells by negat-
ive selection using a magnetic-activated cell sorting sys-
tem (MACS, Miltenyi, Auburn, CA) and magnetic
beads conjugated with antibodies directed against rat
CD45RA (Clone OX-33) and CD8a (Clone G38) to
deplete B cells and CD8+ cells, respectively. The purity
of the selected CD4+ T lymphocyte population on aver-
age was 96%.
Flow cytometry
Unseparated MLN cells and APC or CD4+ T lymphocytes
(2–5 · 105/50 ll) were analysed on a flow cytometer
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(FACScan, Becton Dickinson, San Jose, CA) using the
CELLQuestTM software program.
The following fluorochrome labelled or unlabelled re-
agents were used. We used cell culture supernatants from
the murine hybridomas, designated ME-1 (ATCC, Rock-
ville, MD) or OX-18 (Hybridoma Laboratory, North
Carolina State University), followed by fluoroscein isothio-
cyanate (FITC)-labelled goat anti-mouse immunoglobulin
G (IgG)(c) antibody (Southern Biotechnology, Birming-
ham, AL) to identify HLA-B27 and rat MHC class I
expressing cells, respectively. MHC class II expressing cells
were detected by FITC-conjugated anti-MHC class II
monoclonal antibody (Clone OX-6, PharMingen). Surface
immunoglobulin expressing B cells were identified by
FITC labelled goat anti-rat IgG (H + L) antibody (Kirkeg-
aard & Perry Laboratories, Gaithersburg, MD). CD4+ and
CD8+ cells were identified using phycoerythrin (PE)–anti-
CD4 (Clone W3/25) and FITC–anti-CD8 (Clone OX-8)
monoclonal antibodies (Caltag, Burlingame, CA), respect-
ively. For analyses of MHC class I expression on T and B
cells, FITC-labelled anti-MHC class I monoclonal anti-
body (Clone OX-18, PharMingen) was used together with
PE–anti-CD3 (Clone G4.18) or PE–anti-CD45RA (Clone
OX-33) monoclonal antibodies (PharMingen). To com-
pare CD86 expression on non-TG and TG MLN cells,
monoclonal antibody against CD86 (B7-2; Clone 24F,
PharMingen) was used.
Co-cultures of APC and CD4+ T lymphocytes
APC (3 · 107 cells/8 ml) were pulsed with caecal bacterial
lysate or with keyhole limpet haemocyanin (KLH; Pierce,
Rockford, IL), an unrelated antigen, at 50 or 100 lg/ml
(amount equivalent to optimal concentration determined
for each batch of bacterial lysate) in complete culture
medium (RPMI-1640 supplemented with 5% heat-inacti-
vated fetal calf serum, 2 mM L-glutamine, 1 mM sodium
pyruvate, 50 lM 2-mecaptoethanol, and 50 lg/ml genta-
micin).
The APC were collected after overnight culture and
washed twice to remove soluble bacterial antigens and
other components. They were then either analysed by
flow cytometry or cultured at 3 · 105 cells per well in a
final volume of 02 ml in flat-bottom 96-well plates,
together with 2 · 105 CD4+ cells, in a humidified incu-
bator at 37, 7% CO2. The chosen cell concentrations
were determined by previous studies to be optimal for
IFN-c responses. Triplicate supernatants were harvested
after 3 or 6 days. Supernatants collected on day 6 con-
tained equivalent or only slightly higher amounts of
IFN-c compared to supernatants collected on day 3.
Therefore, analyses of IFN-c detected on day 3 after cul-
ture initiation are shown.
In selected experiments, APC were treated with one or
a combination of the following monoclonal antibodies to
functionally block transgenic HLA-B27, rat MHC class I,
rat MHC class II RT1. B or MHC class II RT1. D (ME-1,
OX-18, OX-6, and OX-17, respectively). Supernatants of
the murine hybridoma cell cultures were concentrated
using an Amicon YM30 membrane to obtain the follow-
ing stock concentrations, ME-1, 07 mg/ml; OX-18,
41 mg/ml; OX-6, 28 mg/ml; and OX-17, 605 mg/ml.
The concentration of isotype control, mouse IgG1 (Clone
107.3, PharMingen) was adjusted to be equivalent to the
highest concentration of each monoclonal antibody used
in blocking experiments. Antibodies were added to APC
at different concentrations as indicated for 30 min. There-
after, APC were either washed to remove the unbound
antibodies or directly added to cocultures with CD4+ T
lymphocytes. No differences were observed in the
amounts of IFN-c produced whether or not the APC
were washed to remove excess antibodies. Results are
shown for experiments in which antibodies remained dur-
ing the entire 3-day cocultures.
Enzyme linked immunosorbent assay (ELISA)
IFN-c was measured in triplicate cell culture supernatants
by ELISA using unlabelled capture antibody (rabbit poly-
clonal anti-IFN-c) and biotin-labelled detection antibody
(monoclonal Clone DB-1; BioSource International, Cama-
rillo, CA), followed by horseradish peroxidase-labelled
streptavidin (PharMingen). The concentration was deter-
mined by comparison to a standard curve generated using
recombinant rat IFN-c (PharMingen).
Statistical analysis
Results from flow cytometric analyses and ELISA are
expressed as mean ± SEM. The probability of zero differ-
ence between the groups was judged by two-tailed Stu-
dent’s t-test. A P-value less than 005 was considered to
be statistically significant.
Results
Compromised function of SPF TG APC
TG rats kept in SPF conditions showed severe and con-
sistent colitis when killed at 4–6 months of age (histol-
ogy scores >3 on a scale of 0–4), consistent with
previous observations.13 In contrast, neither non-TG
littermates exposed to the same microflora nor GF rats
of either genotype developed disease (histologic scores
<05). The MLNs of SPF TG rats were markedly
increased in size and contained 3–10-fold more cells
with a significantly higher percentage and total number
of CD4+ T cells compared to MLNs from non-TG litter-
mates (data not shown), consistent with our previous
observations.23
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MHC-II and HLA-B27-dependent TG T-cell responses
To address the relative roles of HLA-B27 expression on
APC and T cells in mucosal immune responses as well as
the influence of in vivo activation of APC, we studied
CD4+ T lymphocytes, the main source of IFN-c23 from
TG and non-TG rat MLN cocultured with caecal bacterial
lysate-pulsed APC. Caecal bacterial lysate-pulsed APC
from four separate sources (SPF non-TG MLN, SPF TG
MLN, GF non-TG MLN, GF TG MLN) induced a signifi-
cant IFN-c response in CD4+ lymphocytes from SPF TG
rats with colitis (Fig. 1). The IFN-c level was low or
undetectable in cultures of CD4+ cells stimulated with
KLH-pulsed APC (<76 pg/ml of IFN-c was measured),
indicating that secretion of this cytokine depends on
in vitro activation of APC by bacterial components and/or
presentation of bacterial antigens by APC. CD4+ cells
isolated from MLN of non-TG rats did not produce
IFN-c above baseline levels in cocultures with each of the
caecal bacterial lysate-pulsed APC populations studied
(<103 pg/ml of IFN-c was measured). This and our pre-
vious observation that MLN cells from GF TG rats did not
produce IFN-c after in vitro stimulation with caecal bac-
terial lysate23 indicate that prior in vivo activation of CD4+
cells is necessary in order to induce in vitro responses.
We consistently observed that caecal bacterial lysate-
pulsed SPF TG APC stimulated TG CD4+ T cells to
produce significantly less IFN-c than did non-TG APC
(Fig. 1). In addition, lysate-pulsed SPF TG APC
induced less IFN-c than did GF TG APC. To deter-
mine whether or not costimulatory molecules are nor-
mally expressed on SPF TG APC, we evaluated cell
surface CD86 by flow cytometry. As shown in Fig. 2
and Table 1, while a slightly higher proportion of SPF
TG than non-TG APC expressed CD86 prior to pulsing
or after overnight pulsing with KLH (used as an un-
related antigen control), we observed the opposite effect
after pulsing APC with caecal bacterial lysate. The
bacterial lysate induced increased expression of CD86
on both non-TG and TG APC. However, non-TG APC
contained more CD86-expressing cells with higher mean
fluorescence intensity (MFI) compared to cells from TG
littermates. Thus, up-regulation of CD86 by bacterial
components appeared to be compromised in SPF TG
APC.
When caecal bacterial lysate-pulsed non-TG APC from
GF and SPF rats were compared for their ability to stimu-
late SPF TG CD4+ cells, a similar amount of IFN-c was
detected (Fig. 1). Therefore, prior in vivo activation of
APC by exposure to enteric micro-organisms or secon-
dary to chronic inflammation was not required for opti-
mal in vitro stimulation of CD4+ T cells.
It should be noted that IFN-c was detected at very low
levels in supernatants of pulsed APC cultured alone
(<124 pg/ml of IFN-c was measured), even though the
cultures contained a small number of residual T cells (less
than 4% and 8% for non-TG and TG APC, respectively).
Evaluation of MLN cells from SPF and GF TG and
non-TG rats for MHC molecule expression
We next evaluated the expression of rat MHC class I,
MHC class II and transgenic HLA-B27 on TG and non-
TG MLN cells from SPF and GF rats. MLN cells from
TG rats expressed lower levels of endogenous rat MHC
class I compared to cells from non-TG rats (Fig. 3),
as had been previously reported.9 We extended these



















Figure 1. IFN-c production by SPF HLA-B27 TG MLN CD4+ T
lymphocytes cocultured with caecal bacterial lysate-pulsed SPF or GF
APC preparations. Co-culture supernatants were harvested on day 3
and assayed by ELISA. Values represent mean ± SEM of pg/ml of
IFN-c in triplicate culture supernatants. Results shown are represen-
tative of three independent experiments. Statistically significant dif-
ferences between SPF TG and non-TG APC or between SPF and GF
TG APC in inducing IFN-c production by SPF TG CD4+ cells are
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Figure 2. Surface expression of CD86 on T-cell depleted MLN cells
from SPF non-TG (upper panels) and TG (lower panels) rats before
(left column) and after (right column) overnight pulsing with caecal
bacterial lysate. Isotype control staining with FITC labelled mouse
IgG1 is shown as filled histograms. Values indicate percentage of
positive cells and MFI. Results are representative of three independ-
ent experiments.
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of TG rats housed under GF conditions also displayed
lower constitutive levels of rat MHC class I. In addition,
we found that rat MHC class I expression was lower on
both T and B cells of TG compared to non-TG rats,
from both SPF and GF colonies (Fig. 4 and data not
shown). T cells expressed less rat MHC class I than did
B cells and the difference between T- and B-cell rat
MHC class I expression was greater in non-TG com-
pared to TG rats (Fig. 4). Therefore two separate peaks,
one representing B cells with higher levels of MHC class
I expression, another showing T cells with lower
amounts of MHC class I, were consistently noted in the
flow cytometry histograms for non-TG but not for TG
MLN cells (Fig. 4). T-cell depleted non-TG and TG
MLN cells both showed single peak of MHC class I
expression (data not shown). In contrast, freshly isolated
MLN from TG rats, especially SPF TG rats, contained a
higher proportion of cells that expressed MHC class II
than did MLN from non-TG rats (Fig. 5 and Table 1).
In addition, the expression of MHC class II per cell
(mean fluorescence intensity, MFI) was greater on TG
compared to non-TG MLN cells from both SPF and GF
rats. Interestingly, as shown in Table 1, we observed a
Table 1. CD86 and MHC class II expression
on T cell depleted mesenteric lymph node cells Non-TG TG
(%) MFI (%) MFI
CD86
Before pulsing 62 ± 03 208 ± 22 73 ± 07 248 ± 34
KLH pulsing 119 ± 03 205 ± 19 147 ± 08** 250 ± 20
CBL pulsing 513 ± 09 480 ± 25 417 ± 13*** 413 ± 23
MHC class II
Before pulsing 790 ± 12 11839 ± 389 840 ± 10** 16987 ± 382***
KLH pulsing 916 ± 07 11564 ± 550 930 ± 08 19685 ± 334***
CBL pulsing 943 ± 06 31838 ± 392 942 ± 08 29633 ± 427***
Surface expression of CD86 and MHC class II (RT1.B) on T-cell depleted mesenteric lymph
node cells from SPF non-transgenic (non-TG) and TG rats before and after overnight pulsing
with caecal bacterial lysate (CBL) or unrelated antigen KLH was analyzed by flow cytometry.
Results are summarized from four individual experiments including eight non-TG and seven
TG rats. The percentage (%) of positive cells and mean fluorescence intensity (MFI) are


























Figure 3. Analyses of surface expression of rat MHC class I on
freshly isolated SPF or GF MLN cells. Unseparated MLN cells were
incubated with unlabelled hybridoma cell culture supernatant
OX-18. Binding of OX-18 was detected by FITC-labelled goat anti-
mouse IgG(c) antibody. MFI is shown as mean ± SEM. Statistically
significant differences between TG and non-TG cells are denoted by
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Figure 4. Cell surface expression of rat MHC class I. Histograms
showing MHC class I expression on unseparated MLN cells from
SPF non-TG and TG rats, detected by indirect fluorescence using
unlabelled OX-18 followed by FITC labelled goat anti-mouse IgG(c)
(black line) compared to control staining with the FITC-labelled sec-
ondary antibody alone (filled) are shown in the left column. Dot
plots showing MHC class I expression on CD3-positive and CD3-
negative MLN cells are in the middle column. Dot plots showing
MHC class I expression on CD45RA-positive and CD45RA-negative
MLN cells are in the right column. For identification of MHC class I
expression on T and B cells, direct fluorescence of FITC-labelled
anti-MHC class I monoclonal antibody (OX-18) and PE-anti-CD3
or PE-anti-CD45RA monoclonal antibody was evaluated. Histograms
showing all MLN cells are representative of over 30 individual TG
and non-TG rats. Dot plots showing two-colour analysis for MHC
class I and CD3 or CD45RA are representative of three individual
TG and non-TG rats.
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greater increase in MHC class II expression on non-TG
APC following caecal bacterial lysate pulsing (28-fold
higher MFI compared to KLH-pulsed non-TG APC)
than after caecal bacterial lysate pulsing of TG APC
(15-fold higher MFI compared to KLH-pulsed TG
APC), indicating a relative deficiency of TG APC
responses to in vitro restimulation despite their higher
baseline MHC class II expression. All MLN cells from
TG rats expressed HLA-B27 while the non-TG cells did
not (data not shown).
Blocking MHC class II but not rat MHC class I
on APC significantly reduced IFN-c production
by TG CD4+ T lymphocytes
The role of the MHC class I glycoprotein HLA-B27 in the
development of inflammatory disease in either humans or
HLA-B27 TG rats is not well understood. In addition,
while the observations that SPF but not GF HLA-B27 TG
rats develop colitis13,15 and that SPF T-cell deficient TG
rats fail to develop disease10 implicate intestinal micro-
organisms and suggest that T cells from TG rats respond
to enteric bacterial antigens, the role of bacterial antigens
and of host antigen-presenting molecules in T-cell
responses has not been evaluated. To determine if
the pronounced IFN-c response of activated TG CD4+
T lymphocytes to caecal bacterial lysate-pulsed APC
depends on interaction between MHC and T-cell receptor
(TCR) molecules and to examine the relative contribution
of various MHC molecules to activate CD4+ T cells, we
designed experiments to functionally block rat MHC class
I, MHC class II and TG HLA-B27 on APC from SPF TG
and non-TG rats.
For these experiments, serial dilutions of antibodies
directed against rat MHC class I (OX-18), MHC class II
locus RT1.B (OX-6), MHC class II locus RT1.D (OX-17),
and transgenic HLA-B27 (ME-1), were added to caecal
bacterial lysate-pulsed APC prior to the addition of TG
CD4+ T lymphocytes. Treatment of both non-TG and TG
APC with the anti-MHC class II RT1.B antibody signifi-
cantly inhibited, in a dose-dependent manner, cocultured
TG CD4+ T-cell response (50–85% reduction in IFN-c
production, Fig. 6). Non-TG and TG APC-dependent
IFN-c responses were also inhibited, but less effectively,
by the anti-MHC class II RT1.D antibody (39–59% sup-
pression of IFN-c responses, data not shown).
Inhibition of IFN-c production of TG CD4+ lympho-
cytes was equivalent when the anti-MHC class II antibod-
ies remained in the cultures for 3 days or were added to
APC for 30 min and then the excess antibodies were
removed by washing prior to initiation of cocultures
(data not shown).
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Figure 5. Analyses of surface expression of MHC class II (RT1.B
detected by OX-6 monoclonal antibody) on freshly isolated MLN
cells. The percentage of positive cells and MFI are presented as
mean ± SEM. Statistically significant differences between TG and
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Figure 6. Blockade of MHC class II significantly inhibited IFN-c
production induced by caecal bacterial lysate-pulsed APC in cocul-
tures of TG CD4+ T lymphocytes plus non-TG APC (a) or TG APC
(b). Anti-MHC class II RT1.B antibody (OX-6 monoclonal antibody)
at the dilutions indicated, or the isotype control (Con), purified
mouse IgG1 at the amount equivalent to the highest concentration
of OX-6 mAb, was added to the pulsed SPF APC for 30 min before
the start of cocultures with SPF TG CD4+ T lymphocytes. Superna-
tants were harvested at day 3 and assayed by ELISA. Values represent
mean ± SEM of pg/ml of IFN-c in triplicate culture supernatants.
TG CD4+ cells cocultured with an unrelated antigen KLH-pulsed
APC served as a control. Results shown are representative of six
independent experiments. Statistically significant differences between
the amounts of IFN-c produced in cocultures containing APC trea-
ted with anti-MHC class II antibody and in cocultures containing
APC treated with the isotype control are denoted by asterisks
(*P < 005, **P < 001, ***P < 0001).
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The influence of blockade of rat MHC class I on non-
TG or TG APC was also analysed. Addition of anti-rat
MHC class I antibody did not have any significant effect
on IFN-c responses in TG CD4+ cells cocultured with
either TG or non-TG APC (Fig. 7).
Blocking HLA-B27 dramatically suppressed IFN-c
production by TG CD4+ cells cocultured with TG
APC
Experiments were carried out to investigate the role of
transgenic HLA-B27 in the T-cell response. For these stud-
ies, anti-HLA-B27 antibody (ME-1) was incubated with
APC as described above. In cocultures containing caecal
bacterial lysate-pulsed TG APC, the presence of anti-HLA-
B27 antibody caused a marked reduction in IFN-c produc-
tion by TG CD4+ T lymphocytes (Fig. 8b). However, the
inhibition was not complete even at the highest concentra-
tion of antibody (79–87% blockade of IFN-c responses). As
we observed for blocking MHC class II, IFN-c production
was equivalent whether or not the excess anti-HLA-B27
antibody was removed by washing prior to coculture initi-
ation. A small but significant suppression of IFN-c produc-
tion was also noted in cocultures containing non-TG APC
treated with the anti-HLA-B27 antibody (Fig. 8a), most
likely caused by interference with APC–T-cell interaction,
by binding to HLA-B27 on TG T cells.
Blockade of both MHC class II and HLA-B27
eliminated the APC-induced IFN-c response of
TG CD4+ cells
When antibodies against products of the two loci of
MHC class II (OX-6 and OX-17) and HLA-B27 (ME-1)
were added concomitantly, the TG CD4+ T-cell response
was abrogated, reaching levels observed with KLH stimu-
lation (Fig. 9). These results indicate that MHC class II
and HLA-B27 are the antigen-presenting molecules that
activate IFN-c producing CD4+ T cells.
Discussion
The principal goal of this study was to evaluate bacterial






































Figure 7. Blockade of rat MHC class I did not alter IFN-c produc-
tion induced by caecal bacterial lysate-pulsed APC in cocultures of
TG CD4+ T lymphocytes plus non-TG APC (a) or TG APC (b).
Anti-MHC class I antibody (OX-18 monoclonal antibody) at the
dilutions indicated, or the isotype control (Con), purified mouse
IgG1, at the amount equivalent to the highest concentration of
OX-18 mAb, was added to the pulsed SPF APC for 30 min before
the start of cocultures with SPF TG CD4+ T lymphocytes. Superna-
tants were harvested at day 3 and assayed by ELISA. Values represent
mean ± SEM of pg/ml of IFN-c in triplicate culture supernatants.
TG CD4+ cells cocultured with an unrelated antigen KLH-pulsed











































Figure 8. Blockade of HLA-B27 markedly inhibited IFN-c produc-
tion induced by caecal bacterial lysate-pulsed APC in cocultures with
TG CD4+ T lymphocytes. Anti-HLA-B27 antibody (ME-1 mono-
clonal antibody) at the dilutions indicated, or the isotype control
(Con), purified mouse IgG1 at the amount equivalent to the highest
concentration of ME-1 monoclonal antibody, was added to the
pulsed SPF APC for 30 min before the start of cocultures with SPF
TG CD4+ T lymphocytes. Supernatants were harvested at day 3 and
assayed by ELISA. Values represent mean ± SEM of pg/ml of IFN-c
in triplicate culture supernatants of TG CD4+ T lymphocytes cocul-
tured with non-TG APC (a) or TG APC (b). TG CD4+ cells cocul-
tured with an unrelated antigen KLH-pulsed APC served as a
control. Results shown are representative of six independent experi-
ments. Statistically significant differences between the amounts of
IFN-c produced in cocultures containing APC treated with anti-
HLA-B27 antibody and in cocultures containing APC treated with
isotype control are denoted by asterisks (*P < 005, **P < 001,
***P < 0001).
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response in HLA-B27 TG rats with established colitis. The
major findings that emerged are as follows. First, SPF TG
CD4+ T lymphocytes produced high levels of IFN-c in
response to both TG and non-TG APC stimulated with
physiologically relevant bacterial components, whereas
non-TG CD4+ cells did not respond. We have previously
shown that MLN cells from GF TG rats did not produce
IFN-c following in vitro stimulation with caecal bacterial
lysates.23 Thus CD4+ T-cell reactivity that develops in
HLA-B27 TG rats with colitis appears to be dependent on
the genetic susceptibility of the host conferred by expres-
sion of HLA-B27 and in vivo stimulation of T cells by
commensal enteric bacteria. Of interest, APC from both
SPF and GF rats had the capacity to induce IFN-c pro-
duction by CD4+ T lymphocytes from SPF TG rats, indi-
cating that previous activation of APC by in vivo
encounters with enteric bacterial components is not
necessary for antigen-presenting function. Somewhat sur-
prisingly, under these in vitro conditions, SPF TG APC
were less effective inducers of TG CD4+ T-cell responses
than non-TG APC. The reasons for the apparent defect in
SPF TG APC function in vitro are not clear, but one pos-
sible explanation may be that bacterial antigen-pulsed
TG APC do not efficiently up-regulate expression of a key
costimulatory molecule, CD86. Such an interpretation is
consistent with the findings reported recently by Hac-
quard-Bouder et al.24 Their results demonstrate that
HLA-B27 TG dendritic cells form fewer conjugates with T
cells compared to non-TG dendritic cells. Furthermore,
CD86 has been shown to be crucial for conjugate forma-
tion. Another contributing factor might be that constant
activation and challenge in an inflammatory milieu
in vivo could gradually compromise the ability of TG
APC to be further activated in vitro by the same bacterial
antigens and adjuvants. Indeed, it has been reported that
systemic stimulation with a soluble tachyzoite extract can
result in a ‘paralysis’ of murine dendritic cells as evi-
denced by their failure to make IL-12 in response to sub-
sequent in vivo restimulation.25
Second, we consistently observed up-regulated mem-
brane expression of MHC class II and lower levels of
MHC class I on MLN cells of HLA-B27 TG rats, com-
pared to age-matched non-TG controls. TG rats from
both SPF and GF colonies had similar changes in the sur-
face expression of MHC molecules as compared to non-
TG rats from the same housing conditions.
Finally, we demonstrated that the IFN-c response to
caecal bacterial lysate-pulsed non-TG APC was dependent
on molecules encoded by both of the two loci of MHC
class II, while MHC class II and HLA-B27 were the mole-
cules mediating the T-cell response to lysate-pulsed TG
APC. Blocking rat MHC class I on either TG or non-TG
APC had no effect on the T-cell response.
In humans, the MHC class I allele HLA-B27 is
strongly associated with a group of inflammatory dis-
orders that includes ankylosing spondylitis, reactive arth-
ritis, and uveitis/iritis.26 However, the contribution of
HLA-B27 to the pathogenesis of these diseases is still
unresolved. Several hypotheses have been proposed:
(1) HLA-B27 is a particularly efficient restriction ele-
ment for antigenic bacterial or self peptide binding and
presentation; (2) HLA-B27 shares homology in peptide
sequences with some enterobacteria. Presenting such clo-
sely related peptides by host MHC molecules could
potentially lead to cross-reactive immune responses;27–29
(3) peptides derived from HLA-B27 itself are presented
by other MHC molecules;30,31 (4) binding of HLA-B27
heavy chain homodimers to populations of lymphoid
and myeloid cells including APC via recognition of
paired immunoglobulin-like receptors (PIRs) may be
important for the initiation of chronic inflammation.32
(5) it has been reported recently that HLA-B27 misfold-
ing is associated with up-regulation of the unfolded pro-
tein response (UPR) in the endoplasmic reticulum of




































Figure 9. Combined administration of antibodies to MHC class II
and HLA-B27 completely inhibited IFN-c production induced by
caecal bacterial lysate-pulsed APC in cocultures with TG CD4+ T
lymphocytes. Antibodies were added to the pulsed SPF APC for
30 min before the start of cocultures with SPF TG CD4+ T lympho-
cytes. The isotype control, purified mouse IgG1, was added at the
amount equivalent to the highest concentration of the antibodies
used. Supernatants were harvested at day 3 and assayed by ELISA.
Values represent mean ± SEM of pg/ml of IFN-c in triplicate culture
supernatants of TG CD4+ T lymphocytes cocultured with (a) non-
TG APC in the presence of anti-MHC class II RT1. B (OX-6 mono-
clonal antibody, dilution 1 : 50) plus anti-MHC class II RT1. D
(OX-17 monoclonal antibody, dilution 1 : 250) or (b) TG APC in
the presence of anti-MHC class II RT1.B, anti-MHC class II RT1.D,
and anti-HLA-B27 (ME-1 monoclonal antibody, dilution 1 : 25). TG
CD4+ cells cocultured with an unrelated antigen KLH-pulsed APC
served as a control. Results shown are representative of four inde-
pendent experiments. Statistically significant differences between the
APC treated with the specific antibodies and the isotype control
in inducing IFN-c production of TG CD4+ cells are denoted by
asterisks (*P < 005, ***P < 0001).
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that IFN-c further exacerbates activation of UPR-associ-
ated genes.33
In the present study we showed that blockade of HLA-
B27 on TG APC resulted in a dose-dependent suppression
of the IFN-c response by TG CD4+ T lymphocytes cocul-
tured with caecal bacterial lysate-pulsed TG APC. These
results indicate that the role of HLA-B27 is at least parti-
ally to present enteric bacterial peptides. HLA-B27 is unli-
kely to be the source of peptide antigens that are
presented by MHC class II because KLH-pulsed TG APC
did not induce IFN-c responses in TG CD4+ T cells.
In conclusion, caecal bacterial lysate, a complex mix-
ture of physiologically relevant bacterial components
including antigens and adjuvants, can elicit an evident
in vitro IFN-c response in APC-activated TG CD4+ T
lymphocytes. This T-cell stimulation is triggered through
two distinct MHC molecules, HLA-B27 and MHC class II
on TG APC. However, HLA-B27 is not required to sti-
mulate in vitro T cell recall responses to caecal bacterial
lysate, since bacterial lysate-pulsed non-TG APC effi-
ciently induce IFN-c production by TG CD4+ T cells.
Molecules encoded by both of the two rat MHC class II
loci are involved in T-cell activation by APC. Results
shown in the present study provide a more complete
understanding of the pathogenesis of colitis in HLA-B27
TG rats and thus also clarify the role of the immune
response in maintaining chronic intestinal inflammation
in this model system.
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